Consolidated Balance Sheets - USD ($) $ in Millions		Mar. 31, 2025	Dec. 31, 2024
Assets
Cash and cash equivalents		$ 8,334	$ 7,550
Investments		727	665
Accounts receivable, net		26,929	24,227
Inventories		5,176	6,692
Other current assets		2,389	2,732
Assets of businesses held for sale		0	7,004
Total current assets		43,555	48,870
Long-term investments		15,350	15,128
Reinsurance recoverables		4,375	4,378
Property and equipment		3,681	3,654
Goodwill		44,372	44,370
Other intangible assets		29,045	29,417
Other assets		3,003	2,786
Separate account assets		7,277	7,278
TOTAL ASSETS		150,658	155,881
Liabilities
Current insurance and contractholder liabilities		5,984	5,388
Pharmacy and other service costs payable		28,600	28,465
Accounts payable		9,136	9,294
Accrued expenses and other liabilities		8,032	9,387
Short-term debt		3,993	3,035
Liabilities of businesses held for sale		0	2,410
Total current liabilities		55,745	57,979
Non-current insurance and contractholder liabilities		10,309	10,254
Deferred tax liabilities, net		6,879	6,975
Other non-current liabilities		3,579	3,215
Long-term debt		26,455	28,937
Separate account liabilities		7,277	7,278
TOTAL LIABILITIES		110,244	114,638
Contingencies — Note 16
Shareholders' equity
Common stock	[1]	4	4
Additional paid-in capital		31,443	31,288
Accumulated other comprehensive loss		(2,590)	(2,341)
Retained earnings		44,434	43,519
Less: Treasury stock, at cost		(33,065)	(31,437)
TOTAL SHAREHOLDERS' EQUITY		40,226	41,033
Noncontrolling interests		188	210
Total equity		40,414	41,243
Total liabilities and equity		$ 150,658	$ 155,881

[1] Par value per share, $0.01; shares issued, 404 million as of March 31, 2025 and 403 million as of December 31, 2024; authorized shares, 600 million.